Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002941.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 2.88 1.20 1.16
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 1441.76 331.71 21.51
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -0.38 5.15 5.17
Cash -29.10 4.11 5.80
Capex -14.02 < 0.005 < 0.005
Free Cash Flow 105.80 -2.00 0.97
Revenue -85.29 0.61 4.13
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -37.62 0.07 0.10
Operating Margin -71.24 0.03 0.09
ROA -88.04 < 0.005 < 0.005
ROE -88.91 < 0.005 0.04
ROIC -91.41 < 0.005 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002941.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002941.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002941.SZ is permitted for members.